Back
T. Rowe Price Group Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
40
TROW
T. Rowe Price Group
Last Price:
109.51
Seasonality Move:
6.6%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
275.08
Seasonality Move:
4.48%
Sell
40
T. Rowe Price Group (TROW)
is a Sell
Is T. Rowe Price Group a Buy, Sell or Hold?
- The current T. Rowe Price Group [TROW] share price is $109.51. The Score for TROW is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- TROW is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TROW Stock Price Chart
What is T. Rowe Price Group's stock price today?
-
The T. Rowe Price Group share price today is $109.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TROW is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $274.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
TROW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 56.14 | Buy |
| Chaikin Money Flow: | -438090 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.24 - 109.02) | Buy |
| Bollinger Bands (100): | (107.05 - 117.09) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.58 | Buy |
| Relative Strength Index (14 RSI): | 58.54 | Buy |
| Chaikin Money Flow: | 227264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (257.28 - 277.8) | Buy |
| Bollinger Bands (100): | (173.47 - 275.75) | Buy |
TROW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.86 | Buy |
| 20-day SMA: | 106.32 | Buy |
| 50-day SMA: | 108.08 | Buy |
| 200-day SMA: | 111.81 | Sell |
| 8-day EMA: | 108.47 | Buy |
| 20-day EMA: | 107.56 | Buy |
| 50-day EMA: | 108.59 | Buy |
| 200-day EMA: | 110.82 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 273.53 | Buy |
| 20-day SMA: | 264.94 | Buy |
| 50-day SMA: | 262.48 | Buy |
| 200-day SMA: | 194.67 | Buy |
| 8-day EMA: | 272.54 | Buy |
| 20-day EMA: | 269.21 | Buy |
| 50-day EMA: | 257.72 | Buy |
| 200-day EMA: | 211.82 | Buy |
T. Rowe Price Group Earnings Growth & TROW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $0.05 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
T. Rowe Price Group Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||